Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: World J Surg. 2023 Dec 12;48(1):110–120. doi: 10.1002/wjs.12014

Table 1.

Demographic and clinical characteristics of patients with metastatic ACC, stratified by surgical management. Bold indicates p<0.05.

Total Cohort
(n = 976)
Operative Management
(n = 379)
Non-Operative Management
(n = 597)
p-value
Mean Age, Years (SD) 55.2 (15.4) 53.9 (15.5) 56.0 (15.3) 0.035
Sex, n (%)
Male 394 (40.4) 142 (37.5) 252 (42.2) 0.141
Female 582 (59.6) 237 (62.5) 345 (57.8)
Race, n (%)
White 820 (84.0) 322 (85.0) 498 (83.4) 0.475
Black 96 (9.8) 32 (8.4) 64 (10.7)
Other 60 (6.2) 25 (6.6) 35 (5.8)
Ethnicity, n (%)
Hispanic 111 (11.4) 33 (8.7) 78 (13.1) 0.037
Non-Hispanic 865 (88.6) 346 (91.3) 519 (86.9)
Insurance status, n (%)
Private 491 (51.4) 202 (53.3) 289 (48.4) 0.421
Public 419 (43.8) 155 (40.9) 264 (44.2)
Uninsured 46 (4.8) 29 (7.7) 29 (4.9)
Charlson-Deyo Score, n (%)
0 699 (71.6) 272 (71.8) 427 (71.5) 0.8416
1 193 (19.8) 76 (20.1) 117 (19.6)
2 52 (5.3) 24 (6.3) 28 (4.7)
≥3 32 (3.3) 7 (1.8) 25 (4.2)
Laterality, n (%)
Left 500 (51.2) 199 (52.5) 301 (50.4) 0.001
Right 401 (41.1) 167 (44.1) 234 (39.2)
Bilateral 12 (1.2) 2 (0.5) 10 (1.7)
Unspecified 63 (6.5) 11 (2.9) 52 (8.7)
Median Tumor Size, cm (IQR) 11.0 (7.7–15.2) 10.9 (7.5–14.6) 12 (8–17) 0.004
Mean Number of Metastatic Sites, (SD) 1.37 (0.75) 1.15 (0.67) 1.52 (0.76) <0.001
Location of Metastatic Sites
Liver, n (%) 550 (56.3) 166 (43.8) 384 (64.3) <0.001
Lung, n (%) 568 (58.2) 200 (52.8) 368 (61.6) 0.003
Brain, n (%) 35 (3.6) 5 (1.3) 30 (5.0) 0.002
Bone, n (%) 189 (19.4) 61 (16.1) 128 (21.4) 0.037
Medical Therapy, n (%)
Radiation 606 (62.1) 209 (55.1) 397 (66.5) <0.001
Chemotherapy 677 (69.4) 237 (62.5) 440 (73.7) <0.001